T 0377/18 (Regorafenib in solid dispersion/BAYER) of 07.09.2021
- European Case Law Identifier
- ECLI:EP:BA:2021:T037718.20210907
- Date of decision
- 7 September 2021
- Case number
- T 0377/18
- Petition for review of
- -
- Application number
- 05792486.2
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- NEW PHARMACEUTICAL COMPOSITIONS COMPRISING 4-(4-(3-(4-CHLORO-3-TRIFLUOROMETHYL-PHENYL)-UREIDO)-3-FLUORO-PHENOXY)-PYRIDINE-2-CARBOXYLIC ACID FOR THE TREATMENT OF HYPER-PROLIFERATIVE DISORDERS
- Applicant name
- Bayer HealthCare LLC
- Opponent name
- Ter Meer Steinmeister & Partner Patentanwälte mbB
- Board
- 3.3.01
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 56Rules of procedure of the Boards of Appeal 2020 Art 013(2)
- Keywords
- Inventive step - main request, auxiliary requests 1 to 5 (no)
Amendment after summons - taken into account
Amendment after summons - (no)
Admission of TIPA - (no) - Catchword
- -
- Cited cases
- -
- Citing cases
- G 0002/21
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked.